Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Forced Transdifferentiation01:28

Forced Transdifferentiation

1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
1.9K
Introduction to Nuclear Reprogramming01:14

Introduction to Nuclear Reprogramming

1.9K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
1.9K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
Diversity of Antigen Receptors01:28

Diversity of Antigen Receptors

513
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
513

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Reprogramming Stars #28: Stem Cell-Based Approaches to Build Blood Vessels and Liver Tissue-An Interview with Dr. Lay Teng Ang.

Cellular reprogramming·2026
Same author

Protocol for identifying cellular reprogramming minimal networks using combinatorial transcription factor screening.

STAR protocols·2026
Same author

Reprogramming Stars #27: Drawing Inspiration from Reprogramming to Guide Stem Cell Differentiation: An Interview with Dr. Kyle Loh.

Cellular reprogramming·2026
Same author

A combinatorial transcription factor screening platform for immune cell reprogramming.

Cell systems·2026
Same author

Reprogramming Stars #26: Understanding the Reprogramming Privilege-An Interview with Dr. Shangqin Guo.

Cellular reprogramming·2025
Same author

Reprogramming Stars #25: Modeling Brain Aging with Direct Reprogramming of Skin Cells into Neurons-An Interview with Dr. Jerome Mertens.

Cellular reprogramming·2025

相关实验视频

Updated: Jun 4, 2025

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

7.1K

转录因子介导的对抗原呈现细胞的重编程.

Ervin Ascic1, Carlos-Filipe Pereira2

  • 1Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden.

Current opinion in genetics & development
|December 25, 2024
PubMed
概括

本综述探讨了使用转录因子将体细胞重新编程成抗原呈现细胞 (APC),特别是树突细胞 (DC). 这种方法通过产生专门的免疫细胞,对癌症免疫疗法充满希望.

更多相关视频

Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain
08:48

Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain

Published on: October 25, 2016

8.4K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.8K

相关实验视频

Last Updated: Jun 4, 2025

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program
11:00

Reprogramming Mouse Embryonic Fibroblasts with Transcription Factors to Induce a Hemogenic Program

Published on: December 16, 2016

7.1K
Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain
08:48

Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain

Published on: October 25, 2016

8.4K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.8K

科学领域:

  • 免疫学 免疫学 免疫学
  • 细胞生物学 细胞生物学
  • 癌症研究 癌症研究

背景情况:

  • 抗原呈现细胞 (APC),包括树突细胞 (DC) 和巨细胞 (Mφ),对于对抗癌症和感染的免疫反应至关重要.
  • 目前生成APC子集的方法包括从血液中丰富或从干细胞中分化.
  • 细胞发育依赖转录因子 (TFs) 来指定细胞类型.

研究的目的:

  • 为了审查树突细胞 (DC) 亚集规范的转录控制.
  • 要突出涉及生成DCs的转录网络.
  • 讨论直接细胞重编程用于癌症免疫治疗的潜力.

主要方法:

  • 对DC子集的转录规范的文献综述.
  • 对控制APC生成的转录网络的分析.
  • 讨论使用转录因子的转差策略.

主要成果:

  • 转录因子 (TFs) 是APC子集的发展途径中的关键调节者.
  • 直接的细胞重编程 (转基因分化) 可以使用特定的TF组合将体细胞转化为APC.
  • 了解TF网络对于生成所需的APC子集至关重要.

结论:

  • 直接细胞重编程提供了一种新的策略,用于从各种体细胞中生成APC,包括DC.
  • 利用TF组合进行转基因分化,为开发先进的癌症免疫疗法提供了一个有希望的途径.
  • 对DC重编程的进一步研究可以增强基于免疫细胞的癌症治疗.